User menu

Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme

Bibliographic reference Proietti, Marco ; Mairesse, Georges H ; Goethals, Peter ; Scavee, Christophe ; Vijgen, Johan ; et. al. Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme. In: European Journal of Preventive Cardiology, Vol. 24, p. 328-334 (2016)
Permanent URL http://hdl.handle.net/2078.1/187904
  1. Mozaffarian Dariush, Benjamin Emelia J., Go Alan S., Arnett Donna K., Blaha Michael J., Cushman Mary, Das Sandeep R., de Ferranti Sarah, Després Jean-Pierre, Fullerton Heather J., Howard Virginia J., Huffman Mark D., Isasi Carmen R., Jiménez Monik C., Judd Suzanne E., Kissela Brett M., Lichtman Judith H., Lisabeth Lynda D., Liu Simin, Mackey Rachel H., Magid David J., McGuire Darren K., Mohler Emile R., Moy Claudia S., Muntner Paul, Mussolino Michael E., Nasir Khurram, Neumar Robert W., Nichol Graham, Palaniappan Latha, Pandey Dilip K., Reeves Mathew J., Rodriguez Carlos J., Rosamond Wayne, Sorlie Paul D., Stein Joel, Towfighi Amytis, Turan Tanya N., Virani Salim S., Woo Daniel, Yeh Robert W., Turner Melanie B., Heart Disease and Stroke Statistics—2016 Update : A Report From the American Heart Association, 10.1161/cir.0000000000000350
  2. Bhatnagar Prachi, Wickramasinghe Kremlin, Williams Julianne, Rayner Mike, Townsend Nick, The epidemiology of cardiovascular disease in the UK 2014, 10.1136/heartjnl-2015-307516
  3. Townsend Nick, Nichols Melanie, Scarborough Peter, Rayner Mike, Cardiovascular disease in Europe — epidemiological update 2015, 10.1093/eurheartj/ehv428
  4. Kernan W. N., Ovbiagele B., Black H. R., Bravata D. M., Chimowitz M. I., Ezekowitz M. D., Fang M. C., Fisher M., Furie K. L., Heck D. V., Johnston S. C., Kasner S. E., Kittner S. J., Mitchell P. H., Rich M. W., Richardson D., Schwamm L. H., Wilson J. A., , Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, 10.1161/str.0000000000000024
  5. Lansberg Maarten G., O'Donnell Martin J., Khatri Pooja, Lang Eddy S., Nguyen-Huynh Mai N., Schwartz Neil E., Sonnenberg Frank A., Schulman Sam, Vandvik Per Olav, Spencer Frederick A., Alonso-Coello Pablo, Guyatt Gordon H., Akl Elie A., Antithrombotic and Thrombolytic Therapy for Ischemic Stroke, 10.1378/chest.11-2302
  6. Howard Virginia J., High Prevalence of Stroke Symptoms Among Persons Without a Diagnosis of Stroke or Transient Ischemic Attack in a General Population : The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, 10.1001/archinte.166.18.1952
  7. Feigin Valery L, Forouzanfar Mohammad H, Krishnamurthi Rita, Mensah George A, Connor Myles, Bennett Derrick A, Moran Andrew E, Sacco Ralph L, Anderson Laurie, Truelsen Thomas, O'Donnell Martin, Venketasubramanian Narayanaswamy, Barker-Collo Suzanne, Lawes Carlene M M, Wang Wenzhi, Shinohara Yukito, Witt Emma, Ezzati Majid, Naghavi Mohsen, Murray Christopher, Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010, 10.1016/s0140-6736(13)61953-4
  8. Haberman S, Capildeo R, Rose F C, Sex differences in the incidence of cerebrovascular disease., 10.1136/jech.35.1.45
  9. Appelros P., Stegmayr B., Terent A., Sex Differences in Stroke Epidemiology: A Systematic Review, 10.1161/strokeaha.108.540781
  10. Ji R, Arch Neurol, 70, 1 (2012)
  11. Lip Gregory Y. H., Lane Deirdre A., Stroke Prevention in Atrial Fibrillation : A Systematic Review, 10.1001/jama.2015.4369
  12. Yesilot Barlas N, Eur J Neurol, 20, 1431 (2013)
  13. Heuschmann Peter U, Kircher Julia, Nowe Tim, Dittrich Ralf, Reiner Zeljko, Cifkova Renata, Malojcic Branko, Mayer Otto, Bruthans Jan, Wloch-Kopec Dorota, Prugger Christof, Heidrich Jan, Keil Ulrich, Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey, 10.1177/2047487314546825
  14. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, 10.1136/bmj.308.6921.81
  15. Collaboration A. T., Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, 10.1136/bmj.324.7329.71
  16. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, 10.1016/s0140-6736(09)60503-1
  17. Guirguis-Blake Janelle M., Evans Corinne V., Senger Caitlyn A., O'Connor Elizabeth A., Whitlock Evelyn P., Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force, 10.7326/m15-2113
  18. Lopez-Carmona D, Bernal-Lopez MR, Mancera-Romero J, Jansen-Chaparro S, Portales-Fernandez I, Baca-Osorio AJ, Perez-Gonzalez R, Tinahones FJ, Gomez-Huelgas R, Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study, 10.1177/1741826711418166
  19. January C. T., Wann L. S., Alpert J. S., Calkins H., Cigarroa J. E., Cleveland J. C., Conti J. B., Ellinor P. T., Ezekowitz M. D., Field M. E., Murray K. T., Sacco R. L., Stevenson W. G., Tchou P. J., Tracy C. M., Yancy C. W., 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, 10.1161/cir.0000000000000041
  20. , Camm A. J., Lip G. Y. H., De Caterina R., Savelieva I., Atar D., Hohnloser S. H., Hindricks G., Kirchhof P., Bax J. J., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Kirchhof P., Knuuti J., Kolh P., McDonagh T., Moulin C., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Tendera M., Torbicki A., Vahanian A., Windecker S., Vardas P., Al-Attar N., Alfieri O., Angelini A., Blomstrom-Lundqvist C., Colonna P., De Sutter J., Ernst S., Goette A., Gorenek B., Hatala R., Heidbuchel H., Heldal M., Kristensen S. D., Kolh P., Le Heuzey J.-Y., Mavrakis H., Mont L., Filardi P. P., Ponikowski P., Prendergast B., Rutten F. H., Schotten U., Van Gelder I. C., Verheugt F. W. A., , , 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association, 10.1093/eurheartj/ehs253
  21. Furie K. L., Kasner S. E., Adams R. J., Albers G. W., Bush R. L., Fagan S. C., Halperin J. L., Johnston S. C., Katzan I., Kernan W. N., Mitchell P. H., Ovbiagele B., Palesch Y. Y., Sacco R. L., Schwamm L. H., Wassertheil-Smoller S., Turan T. N., Wentworth D., , Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, 10.1161/str.0b013e3181f7d043
  22. Hsu Jonathan C., Maddox Thomas M., Kennedy Kevin, Katz David F., Marzec Lucas N., Lubitz Steven A., Gehi Anil K., Turakhia Mintu P., Marcus Gregory M., Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke, 10.1016/j.jacc.2016.03.581